Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.-Reference-Cited by-同舟云学术

Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration.

Published:1980-11 Issue:5 Volume:10 Page:449-452
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:British Journal of Clinical Pharmacology

Author:

Warrington SJ,Turner P,Kilborn JR,Bianchetti G,Morselli PL

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1980.tb01787.x/fullpdf

Reference5 articles.

1. Cardiovascular effects of single oral doses of the new β-adrenoceptor antagonist SL75212 in healthy volunteers;BIANCHETTI;Br. J. clin. Pharmac.,1979

2. A sensitive gas-chromatographic method for the determination in blood and urine of SL 75212, a new β-adrenoceptor blocking agent;BIANCHETTI;J. Chromat.,1979

3. Preliminary studies on SL 75212, a new potent cardioselective β-adrenoceptor antagonist;BOUDOT;Br. J. Pharmac.,1979

4. The spectrofluorimetric estimation and buccal absorption of SL 75212, a novel β-adrenoceptor antagonist;DAVIS;Br. J. clin. Pharmac.,1979

5. IGPHARM: Interactive graphic package for pharmacokinetic analysis;GOMENI;Computers and Biomedical Research,1978

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Betaxolol as a Potent Inhibitor of NDM-1-Positive E. coli That Synergistically Enhances the Anti-Inflammatory Effect in Combination with Meropenem;International Journal of Molecular Sciences;2023-08-29

2. Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup;Critical Care;2021-06-10

3. Inhibitory action of betaxolol, a β-selective adrenoceptor antagonist, on voltage-dependent calcium channels in guinea-pig artery and vein;British Journal of Pharmacology;1995-05

4. REGIONAL HEMODYNAMIC-EFFECTS OF BETAXOLOL, A NEW SELECTIVE BETA-1-BLOCKER, AND ATENOLOL IN CONSCIOUS SPONTANEOUSLY HYPERTENSIVE RATS;JPN J PHARMACOL;1992

5. Dose-Dependent Effects of Betaxolol in Hypertension: A Double-Blind, Multicenter Study;The Journal of Clinical Pharmacology;1992-04